Sanofi makes “strategic investment” in biotech developing second-generation obesity drug

The biotech firm Resalis Therapies is creating a prospective second-generation obestity therapy based upon study from Aalborg College, to name a few.

发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/sanofi-makes-strategic-investment-in-biotech-developing-second-generation-obesity-drug/

(0)
上一篇 31 10 月, 2024 8:18 上午
下一篇 31 10 月, 2024 8:18 上午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。